Disclaimer

The contents of this webpage are provided by the individual and/or office stated below. Unless the page falls under the university’s Regulations for Teaching and for Examinations, Laboratoria Smeets is not bound by the information provided.

On account of the rapid evolution of legislation and our higher education environment, it is possible that the information is no longer completely accurate. Where necessary, Laboratoria Smeets can adjust and update faulty information.

Laboratoria Smeets has taken all reasonable care to ensure that all information available on its websites is accurate at the time of publication and on the basis of the current state of knowledge.

Laboratoria Smeets is not responsible for the content of any links to external organisations that are referred to on its website.

LABORATORIA SMEETS N.V.

Fotografielaan 42
B-2610 Antwerpen-Wilrijk
Tel. +32 (0)3 828 29 37
Fax +32 (0)3 830 21 36
e-mail: info@labosmeets.be

EN  NL  FR  DE  ES 
CASE:  

Read more...

Read more...
CASE: New Technology for API solubility  

In collaboration with the University of Ghent, Labo Smeets has realised a new process in pharmaceutical extrusion technology, which enables us to make highly soluble granules. The main application is to make pharmaceutical granule compositions to drastically improve water solubility of active ingredients. The technology is applicable for the following drug ...
Read more...
New Technology for API solubility

In collaboration with the University of Ghent, Labo Smeets has realised a new process in pharmaceutical extrusion technology, which enables us to make granules. The main application is to make pharmaceutical granule compositions to drastically improve water solubility of active ingredients. This equipment is installed and available since January 2011.

Read more...
CASE: Product innovation  

A customer identified a patented technology at one of the Belgian universities to make one of their products easier to administer. We were contacted at an early stage to help with developing the product. We jointly decided to set up a test manufacturing unit in order to produce small batches for the clinical trials. As the project outcome was uncertain, ...
Read more...
CASE: Speed to market  

A customer found an opportunity to launch an anti-allergic product in one of its markets. The opportunity came up quickly, but the product design wasn’t ready, nor were the sales forecasts. The marketing team instructed to identify the swiftest supplier to realize the product launch. In less than 2 weeks, we were able to present a fully elaborated ...
Read more...
CASE: Strategic procurement  

One of  our pharmacuetical customers is a large consumer of raw materials. Often large pharmaceutical customers are constrained with their raw materials procurement strategies. The complexity of the regulatory filing for many of their products, prevents them from obtaining the best deal. Underlying causes are the intrinsic speed of action, but also the ...
Read more...